The Pharmacy Times® Oncology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
What can we help you find?
Pembrolizumab (Keytruda) has demonstrated promising activity when used in combination with chemotherapy or quavonlimab in select patients with nonsquamous non–small cell lung cancer.
The Mary Pazdur Award was presented during the JADPRO Live Virtual conference.
Pharmacy Times® interviewed Petros Grivas, associate professor at the University of Washington and Fred Hutchinson Cancer Research Center and a medical oncologist at Seattle Cancer Care Alliance, on the value of the pharmacist in the treatment of patients with cancer during COVID-19.
Week in Review: Herpes Zoster Ophthalmicus Could Be Rare Manifestation of COVID-19, Possibly Caused by Stress
Top news of the week from Pharmacy Times.
Women diagnosed with cancer as adolescents or young adults can be especially vulnerable to the impact of the disease and its treatment on their ability to work.
Despite it being fall, sun safety is important all year and even needs to be considered for winter sport activities, such as snowboarding and skiing.
Evidence-based cancer regimens have been shown to result in better outcomes, including longer survival and less toxicity.
The COVID-19 pandemic has caused many routine colorectal cancer screenings to be delayed.
The research found that obese patients with diabetes were significantly less likely to develop pancreatic cancer if they had undergone bariatric surgery, with the majority of the patients in the study being female.
Enfortumab vedotin-ejfv (Padcev) elicited durable responses in patients with locally advanced or metastatic urothelial cancer who received previous treatment with a PD-1/PD-L1 inhibitor.
Study: Single Dose Radiotherapy Equally Effective as Conventional Radiotherapy for Most Breast Cancer Cases
The authors concluded that a single dose of targeted intraoperative radiotherapy should be an option accessible to health care providers and discussed with patients.
Bacteria in the gut may play a role in the treatment outcomes of patients with prostate cancer taking oral medications, according to a recent study.